Abstract: G-CSF and GM-CSF play important roles in regulating neutrophil production, survival, differentiation, and function. However, we have shown previously that G-CSF/GM-CSF double-deficient [knockout (KO)] mice still develop a profound neutrophilia in bone marrow and blood after infection with Candida albicans. This finding suggests the existence of other systems, which can regulate emergency neutrophil production. We have now developed an "in vitro" technique to detect and characterize a neutrophil-promoting activity (NPA) in the media conditioned by mouse embryonic fibroblasts (MEFs) derived from G-CSF 
INTRODUCTION
Multipotential hematopoietic stem cells can differentiate into all lineages of blood cells, and this process is regulated by specific sets of growth factors/cytokines [1] [2] [3] . The development of the myeloid cell lineage from hematopoietic stem cells occurs through several stages within the bone marrow and is regulated by the cytokines stem cell factor (SCF), IL-3, G-CSF, GM-CSF, IL-6, and M-CSF. In particular, G-CSF maintains neutrophil production at steady-state and increases production in emergency situations [4, 5] , GM-CSF sustains viability and potentiates the functions of neutrophils, eosinophils, and macrophages [4] , and M-CSF affects granulocyte production indirectly by enhancing the production of G-CSF [6] and GM-CSF [7] .
The pivotal role of G-CSF and GM-CSF in "in vivo" granulopoiesis has been demonstrated through pharmacological administration [4] or by genetic ablation of the corresponding genes [5, 8 -11] . However, recent findings using G-CSF/GM-CSF double-deficient mice (G
) have suggested the existence of other regulators of neutrophil production. In previous studies, we have demonstrated that although G-CSFdeficient mice are neutropenic, they develop a profound neutrophilia when challenged with Candida albicans [12] . Similarly, an increase in neutrophil numbers in peripheral blood is observed in GM-CSF/G-CSF double-knockout (KO) mice and in G-CSF/IL-6 double-KO mice challenged with C. albicans for 7 days [12, 13] . As these mice cannot produce any biologically active G-CSF or GM-CSF [5, 11] , these observations suggest that the proliferation and differentiation of bone marrow cells at the GM-progenitor level may be stimulated by another cytokine pathway. Indeed, we have previously demonstrated enhanced granulopoiesis "in vitro" when stromal cells from G-CSF and GM-CSF double-deficient mice are exposed to C. albicans [13] .
To extend these findings and to characterize the putative neutrophil-promoting activity (NPA), we have developed a robust liquid culture assay system for the detection of NPA in media conditioned by primary and immortalized embryonic fibroblasts from G Ϫ/Ϫ , GM Ϫ/Ϫ mice. We show that the level of NPA in culture medium conditioned by embryonic fibroblasts is strongly enhanced after stimulation of the cells with pathogen(s). Using embryonic fibroblasts from G-CSF/GM-CSF/ M-CSF triple-KO mice (G Ϫ/Ϫ , GM Ϫ/Ϫ , M Ϫ/Ϫ ) or blocking
Primary murine embryonic fibroblast (MEF) culture
ϩ/Ϫ pregnant female mice were killed on the 13th-15th day of pregnancy by cervical dislocation. Embryos were washed with PBS. Soft tissues (i.e., liver, heart, and other viscera) were removed, and embryonic carcasses were digested in trypsin at 37°C for 30 min followed by overnight incubation at 4°C. Embryonic fibroblasts were cultured in DMEM containing 15% HI FCS. When confluent, cells were subcultured at a dilution of one in three. Cells from individual embryos were also collected at this time for genotyping.
Immortalization of embryonic fibroblasts
Embryonic fibroblasts were immortalized by transfection with SV40 T vector pT22 [16] , from Professor Phil Gallimore (University of Birmingham, UK). Primary embryo fibroblasts were passaged 24 h before electroporation to ensure logarithmic growth. Cotransfections were carried out using a 20:1-g ratio of pSV40-T plasmid DNA and pTK-hyg plasmid DNA (Clontech, Palo Alto, CA, USA). Cells were transfected by electroporation in a 0.4-cm cuvette, pulsed at 260V/960F using a gene pulser (Bio-Rad Laboratories, Hercules, CA, USA). Forty-eight hours after electroporation, cells were passaged and selected in 100 g/ml hygromycin B (Roche, Dee Why, New South Wales, Australia). Transfected cells were subcloned further in soft agar. Stable expression of SV40-T was confirmed by PCR.
Detection of SV40 large T antigen
Specific primers for SV40 large T antigen [17] were sense: 5Ј CCT GGC TGT CTT CAT CAT C 3Ј; antisense: 5Ј CAT GAA TGA GTA CAG TGT GCC 3Ј.
PCR analysis was performed on DNA from hygromycin-selected clones and yielded a product of 340 bp.
PCR diagnosis of M-CSF genotype
Mice and embryos were genotyped at the M-CSF locus by PCR analysis. The primers to identify the op allele were designed to amplify the segment containing the op mutation on Chromosome 3 [8] . The two primers used were sense: 5Ј GAT CCT GTT TGC TAC CTA AAG AAG GCC ATT TT 3Ј; antisense: 5Ј GTA AGG TTC AGG CTC GGT GAG CAT AT 3Ј. The PCR products were digested with BSTX I at 45°C and run on a 4% agarose gel (Reliant 4% Tris-boric acid-EDTA buffer gel, MC54929). Under these conditions, the wild-type (M ϩ/ϩ ) produces two bands of 30 bp and 230 bp; homozygous (op/op, M Ϫ/Ϫ ) only produces a 263-bp band, and heterozygous (op/ϩ, M ϩ/Ϫ ) produces three bands of 263 bp, 233 bp, and 30 bp.
Production of CM
Primary culture (P1) MEFs were passaged at 1:3 dilution. After overnight incubation, passage 2 (P2) embryonic fibroblasts were stimulated with LPS (0.05 g/ml) or with 1 ϫ 10 8 HI C. albicans (ATCC 18804) per 175 cm 2 flask in phenol red-free DMEM (Gibco, Invitrogen, Carlsbad, CA, USA), supplemented with 1% human albumin solution (CSL, Australia) and 1 mM sodium pyruvate (Gibco, Invitrogen). CM were harvested after 48 h.
SV40 T-transfected cell lines, seeded at 1 ϫ 10 7 cells per 175 cm 2 flask the day before stimulation, were stimulated with LPS or HI C. albicans as described in the preceding paragraph, and CM were harvested after 48 h.
Bone marrow assay

GM
Ϫ/Ϫ G Ϫ/Ϫ mice were injected i.p. with 4 mg cyclophosphamide (Sigma Chemical Co.) in 0.2 ml PBS 3 days before assay to enrich for myeloid progenitors. Femora from at least two mice were used for each experiment. The bone marrows were flushed into 5 ml low-density (1.060 g/ml) metrizamide (ICN, Costa Mesa, CA, USA; Cat. #195324 [18] ) or Histopaque (Sigma Chemical Co.) and dispersed to yield a single-cell suspension, which was layered over high-density (1.080 g/ml) metrizamide or Histopaque solution and centrifuged at 1500 g for 15 min at 4°C. The band of low-density cells at the interface was collected and washed with culture medium. Cells were cultured in eight-well LabTek chamber slides (Nunc, Rochester, NY, USA) at 5 ϫ 10 3 cells/well in a total volume of 200 l 1:1 RPMI and IMEM, supplemented with 10% HI FCS and nonessential amino acids (all Gibco products from Invitrogen). After 4 days in culture, the slides were stained with May-Grumwald Giemsa for 4 min followed by 3% Giemsa's stain (both from BDH, Merck, Darmstadt, DL, Germany) for 7 min. Granulocyte clusters, containing between five and 50 cells, were identified by morphology or by specific staining with naphthol AS-D chloroactetate esterase. NPA activity is expressed in units/ml. One unit is defined as the activity required to generate one granulocyte cluster from 5 ϫ 10 3 bone marrow cells after 4 days in this liquid culture assay.
Naphthol AS-D chloroacetate esterase staining
Slides were air-dried, fixed in formalin vapor for 4 min, rinsed in water, and stained using the Naphthol AS-D chloroacetate (specific esterase) kit (Sigma Chemical Co.), according to the manufacturer's instructions. Cells were counterstained with hematoxylin.
Microscopy
Slides were examined using a Nikon Microphot-FX microscope. Images were acquired using a 20ϫ plan or 100ϫ plan (oil) lens and a diagnostic imaging spot camera.
FACS analysis
Bone marrow cells from cyclophosphamide-treated G Ϫ/Ϫ GM Ϫ/Ϫ mice were harvested and enriched for myeloid progenitors as described above. The cells were divided into three samples: One was processed directly for antibody staining and FACS analysis, and the other two were transferred to flasks and cultured with or without CM from C. albicans-stimulated G Ϫ/Ϫ GM Ϫ/Ϫ embryonic fibroblasts as a source of NPA. Cultured cells were harvested after 4 days and processed for antibody staining and FACS analysis. Single-cell suspensions (0.5-2ϫ10 6 cells per tube) were incubated with a combination of FITC-labeled anti-Mac-1 (M1/70) and PE-labeled anti-Gr-1 (Rb6-8C5A) or FITC-labeled anti-Flt-3 and PE-labeled anti-Kit antibodies in FACS buffer (5% FCS, 5% EDTA in mouse toxicity PBS) for 20 -30 min. Washed cells were analyzed on a FACScan (Becton Dickinson, North Ride, New South Wales, Australia). Nonspecific binding of antibodies to FcRs (Fc␥III/II) was reduced by preincubating the cells with Fc-block (BD Biosciences PharMingen, San Diego, CA, USA) for 10 min on ice. The data were plotted and analyzed using the statistical software in CellQuest Use of neutralizing antibodies during NPA production and in bone marrow assays
To monitor the requirement for M-CSF during NPA production, SV40 Ttransformed cells (SV#23) were stimulated with LPS (0.05 g/ml), alone or combined with anti-M-CSF antibody (M9082) or anti-c-fms antibody (AFS98) at different concentrations. Parallel cultures of SV#43 cells were incubated with LPS and control antibodies to mouse SCF (S-6045) or to cytokeratine 19 (SC-33119): These antibodies are polyclonal antibodies produced in goats and are matched to the M-CSF antibody M9082. After 48 h culture, CMs were harvested and tested in bone marrow assays.
To block growth factor receptors on the target bone marrow cells, cells were incubated with anti-c-fms antibody (AFS98) or with anti-SCF receptor antibody (ACK-2; 10ϫ concentrated from hybridoma supernatants) in a chamber slide at 37°C for 30 min before adding the growth factors or CM. To neutralize the action of growth factors, blocking antibodies (anti-M-CSF antibody M9182) were incubated with growth factors or CM at 37°C for 30 min in a chamber slide before adding the bone marrow cells. Culture conditions, staining of the slides, and scoring of granulocyte clusters were performed as described previously [13] .
Supplementation of MEF cultures with M-CSF
were stimulated with LPS (0.05 g/ml), alone or combined with M-CSF (5 ng/ml). The CMs were harvested 48 h later and tested in the bone marrow assay. For some experiments, suspensions of embryonic fibroblasts were divided into two parts immediately after isolation from embryo bodies. One part was cultured in normal medium, the other, in medium containing M-CSF (5 ng/ml). One day before stimulation, cells from each of the cultures were trypsinized, washed, and seeded at 1 ϫ 10 5 cells/well in 24-well plates and then, stimulated with LPS (5 g/ml), alone or combined with M-CSF (5 ng/ml). The CMs were harvested after 48 h culture and tested in a bone marrow assay.
, M-CSF (5 ng/ml) was kept in the culture medium throughout the isolation of the cells from embryos, transfection, and selection in hygromycin. To obtain the CM, these cells were stimulated with LPS alone or combined with M-CSF.
Cytokine array analysis
embryos were incubated in medium, with or without LPS (0.05 g/ml), as described in Production of CM above. The CM were collected after 48 h. RayBio mouse cytokine antibody array membranes (Array II, RayBiotech, Norcross, GA, USA) were incubated with the individual CM overnight and then processed according to the manufacturer's instruction manual. Reactivity with individual antibodies was visualized with ECL reagent (Amersham, Piscataway, NJ, USA). Multiple exposures of each film were obtained to ensure linearity of detection.
RESULTS
Identification of granulocytes generated in liquid culture assays
Our previous studies indicated that CM from bone marrow stromal cell cultures exposed to HI C. albicans supported myeloid colony-forming cells in soft agar clonogenic assays [13] . We also generated CM from various tissues of G Ϫ/Ϫ GM Ϫ/Ϫ mice and compared them for their ability to support neutrophil colonies in soft agar cultures and found that CM from primary embryonic fibroblasts (MEFs) had the highest NPA (S. Basu and Melissa Katz, unpublished results).
We have now developed a liquid culture assay to detect NPA in CM. Bone marrow cells from cyclophosphamide-treated G Ϫ/Ϫ GM Ϫ/Ϫ mice, enriched for myeloid progenitors by metrizamide density gradient [18] , were cultured on chamber slides with purified cytokines or CM from double-KO (G Ϫ/Ϫ GM Ϫ/Ϫ ) MEFs. After 4 days, the number and type of myeloid cell clusters were assessed by morphology (Fig. 1, a, b, d , f, and h) and by staining for specific esterase (Fig. 1, c , e, g, and i). ␣-Naphthol AS-D choloroacetate esterase staining shows localized, blue granular staining in the cytoplasm of nearly all neutrophilic granulocytes, and monocytes, macrophages, and lymphocytes do not react [19] . The specificity of this stain is clearly seen in Figure 1e , where macrophages and monocytes show no reactivity, and cells morphologically identifiable as granulocytes show strong positivity for this stain.
Without any added stimulus, only a few monocytes and adherent cells survived after 4 days of incubation (Fig. 1a) . M-CSF promoted the survival of monocytes and stimulated the generation of monocyte clusters but did not support the formation of granulocytic clusters (Fig. 1, b and c) . GM-CSF stimulation supported granulocyte and monocyte clusters plus a diffuse, adherent cell population (Fig. 1, d and e), SCF predominantly gave rise to granulocyte clusters (Fig. 1, f and g) , and CM from G Ϫ/Ϫ GM Ϫ/Ϫ MEFs exposed to HI C. albicans supported the proliferation of monocytes and granulocytes (Fig.  1, h and i) .
We also performed FACS analysis to monitor the generation of specific blood cell types in the liquid cultures. Bone marrow cells from G Ϫ/Ϫ GM Ϫ/Ϫ mice collected immediately after metrizamide separation (before culture) or collected after 4 days in liquid culture, with or without CM, were stained with lineage-specific antibodies: Expression of Kit and Flt-3 was used to identify stem cells/early progenitor cells and Mac-1 and Gr-1 to identify cells in the myeloid/monocyte lineage [20] . Antibody reactivity was assessed by FACS analysis (Fig. 2) . After culture of the cells in NPA, there was a substantial increase in the proportion of cells positive for Flt-3 and doubly positive for Flt-3 and Kit (cf., Fig. 2, A and B) , suggesting an expansion of the early hematopoietic progenitors with myeloid proliferation potential [21, 22] . It is most striking that NPA strongly enhanced the proportion of Gr-1/Mac-1 double-positive cells (Fig. 2B) , supporting the notion that under the influence of NPA, granulocytes and monocytes are the main cell types generated in liquid culture. In contrast, culture of the cells in control medium resulted in cell death (data not shown), with few surviving cells of myeloid origin (Fig. 2C ).
Primary and transformed embryonic fibroblasts from GM-CSF Ϫ/Ϫ /G-CSF Ϫ/Ϫ mice produce high levels of NPA when stimulated with C. albicans Primary embryonic fibroblasts (MEFs) from G Ϫ/Ϫ GM Ϫ/Ϫ mice were exposed to control medium or to HI C. albicans for 48 h. The resulting CMs were tested for their ability to promote clusters of granulocytic cells in a liquid bone marrow assay. We consistently observed strong increases in NPA activity with media conditioned in the presence of HI C. albicans (Fig. 3A) . CM from MEFs exposed to C. albicans stimulated bone marrow progenitors to produce a cell population similar to that observed in cultures stimulated by GM-CSF; i.e., granulocyte and monocyte clusters as well as adherent cells (Fig. 1d) . HI C. Myeloid cells are generated during in vitro culture with CM from G-CSF/GM-CSF-deficient fibroblasts. Progenitor-enriched bone marrow cells were tested before in vitro culture (A), after 4-day culture in medium conditioned by double-KO MEFs exposed to C. albicans (B), or after 4 days culture in control medium (C). Cells were analyzed by FACS after staining with FITC (abscissa)-or PE (ordinate)-labeled antibodies. Quadrants for each population were set using FITC-or PE-labeled irrelevant antibodies, and the proportion of cells in each quadrant was determined using CellQuest.
albicans, added directly to the bone marrow progenitor cell cultures, did not stimulate cell production (not shown).
Primary MEFs have restricted proliferative potential in vitro [23] , thus limiting their use as a substantial source of NPA. We decided to generate immortalized MEF cell lines in an attempt to overcome this problem. MEFs derived from double-KO G Ϫ/Ϫ GM Ϫ/Ϫ mice were transfected with a vector encoding SV40 T antigen [16] , and permanent cell lines were subsequently derived by selection in medium containing hygromycin. Clonal isolates of the immortalized cells were stimulated by C. albicans and the resulting CM tested in the bone marrow progenitor cell assay. As for primary fibroblast cultures, production of NPA was enhanced significantly after exposure of the cells to C. albicans (PϽ0.001; Fig. 3B ). Isolate #23 was cloned further in soft agar, and Clone SV#23-C4 was chosen as a source of CM for all further studies. Major advantages of using the immortalized fibroblasts were the significant reduction in background (unstimulated) NPA levels, the more reproducible quality of the CM (Fig. 3, A and B) , and the ability to grow large-scale cultures.
LPS enhances NPA production significantly by embryonic fibroblasts LPS has various biological effects on mammalian hosts and their cells, one of which is to stimulate the secretion of many biologically active cytokines and mediators [24] . We compared LPS to HI C. albicans for the induction of NPA secretion in SV40-immortalized cell lines. LPS was a much stronger stimulus for NPA production than C. albicans (Fig. 4A) , and granulocyte clusters stimulated by LPS CM were more numerous and larger (Fig. 4C) . The identity of the cell types generated with LPS CM was confirmed by FACS analysis and ␣-naphthol AS-D chloroacetate esterase staining.
As LPS has been reported to stimulate hemopoietic progenitor cells directly through the TLRs [25] , and LPS still present in the CM may thus affect granulocyte cluster formation directly, we tested the effect of adding LPS to the liquid culture at the time of assays. LPS did not increase granulocyte cluster numbers when added directly to bone marrow cells, nor when used to supplement CM from stimulated or unstimulated MEFs (Fig. 4B, solid bars) . Thus, LPS does not act directly on the bone marrow progenitor cells but like C. albicans, caused the secretion of a cytokine or factor, other than G-CSF or GM-CSF, which stimulates granulocyte production in vitro.
M-CSF is required for NPA production
The main target cells activated by LPS are monocytes and macrophages [26] , and macrophages are a major source of many cytokines involved in the immune responses, hematopoiesis, inflammation, and other homeostatic processes [27] . LPS has been reported to enhance the production of M-CSF by human marrow stromal cells and monocytes [27, 28] and of GM-CSF by monocytes [29] . Although M-CSF action is restricted mainly to the macrophage lineage [30] , M-CSF induces the synthesis of several growth factors, including IL-1, G-CSF, IFN, and TNF [26] . It was of interest therefore to test the role of M-CSF in the production of NPA by LPS-stimulated embryonic fibroblasts. We obtained MEFs of different genotypes from intercrosses between G Ϫ/Ϫ GM Ϫ/Ϫ M ϩ/Ϫ mice (M. L. Hibbs, C. Quilici, N. Konfouri, T. F. Seymour, J. E. Armes, A. W. Burgess, A. R. Dunn, manuscript submitted) and assessed their ability to produce NPA when exposed to LPS (Fig. 5) . NPA levels in the CM correlated with M-CSF gene dosage: On a null background for G-CSF and GM-CSF, M-CSF ϩ/Ϫ MEFs produced an intermediate level of NPA compared with M-CSF ϩ/ϩ , and NPA activity from M-CSF Ϫ/Ϫ MEFs was undetectable (Fig. 5A) .
To further define the requirement for M-CSF in NPA production, we added M-CSF to the G Ϫ/Ϫ GM Ϫ/Ϫ M Ϫ/Ϫ and G Ϫ/Ϫ GM Ϫ/Ϫ M ϩ/Ϫ MEFs during stimulation with LPS. NPA production by cells of both genotypes was augmented by M-CSF, particularly from G Ϫ/Ϫ GM Ϫ/Ϫ M Ϫ/Ϫ MEF (Fig. 5B) . However, NPA production was still much lower than in G Ϫ/Ϫ GM Ϫ/Ϫ M ϩ/Ϫ MEF stimulated by LPS alone (PϽ0.01). Thus, this artificially reconstituted system did not mimic natural NPA production completely.
One explanation for low NPA production by G Ϫ/Ϫ GM Ϫ/Ϫ M Ϫ/Ϫ MEFs, even when M-CSF was included in the culture, could be selective loss of a M-CSF-dependent cell type respon- sible for NPA production. To rescue putative M-CSF-dependent cells, we therefore added M-CSF to the MEF culture from the time of embryo isolation. As soon as embryos were dissected and trypsinized, each embryo's fibroblast was divided into two parts and cultured in medium containing 5 ng/ml M-CSF or in normal medium. When the cells were cultured for the production of CM, each set of cells was divided further into two groups: one stimulated with LPS alone and the other stimulated with LPS plus M-CSF. The resultant CM was then compared for NPA activity in the bone marrow progenitor cell assay ( Table 1) .
M-CSF added to the cultures from the beginning but not during stimulation with LPS enhanced NPA production by approximately twofold for G (Table 1) . However, the amount of NPA activity in G Ϫ/Ϫ GM Ϫ/Ϫ M Ϫ/Ϫ MEFs established in M-CSF was still fourfold lower than that observed in G
The enhancement of NPA production in the G Ϫ/Ϫ GM Ϫ/Ϫ M Ϫ/Ϫ MEFs established in M-CSF did not result from carryover of M-CSF from the primary cultures, as the cells were trypsinized and washed extensively prior to culture for CM production. Addition of M-CSF in the medium during primary culture and stimulation with LPS enhanced NPA secretion only marginally, relative to no addition during the stimulation phase (Table 1) . Thus, although exposure to M-CSF from the moment of MEF isolation partially restored NPA production, triple null fibroblasts did not produce as
MEFs, even when exogenous M-CSF was present during cell expansion and CM production.
We generated a SV40-transfected MEF cell line from the G Ϫ/Ϫ GM Ϫ/Ϫ /M Ϫ/Ϫ embryonic fibroblasts. To avoid the loss of potential M-CSF-dependent cells, cells were kept in M-CSF (5 ng/ml)-containing medium as soon as they were isolated from the embryos and during the transfection and selection steps. These cells (T-SV#22), immortalized and expanded in the constant presence of M-CSF, were then stimulated with LPS or HI C. albicans in the presence or absence of M-CSF (Fig. 5C) . M-CSF, added during the production of CM, enhanced NPA production significantly by immortalized fibroblasts, irrespective of the stimulus (Fig. 5C, PϽ0.05) ; however, once again, the NPA level was much lower than that obtained from the M-CSF ϩ/ϩ cell line (SV#23). M-CSF alone, i.e., without addition of LPS or C. albicans, did not stimulate neutrophil clusters.
Role of M-CSF in the production of NPA by cells expressing the M-CSF gene product
The results obtained with G Ϫ/Ϫ GM Ϫ/Ϫ /M Ϫ/Ϫ embryos clearly show that M-CSF plays a critical role in NPA production. To confirm these results, we tested LPS-induced NPA production by immortalized G Ϫ/Ϫ GM Ϫ/Ϫ M ϩ/ϩ cells (SV#23) in the presence of M-CSF-neutralizing antibody or with blocking anti-cfms antibodies. Anti-M-CSF and anti-c-fms antibodies reduced NPA production significantly (PϽ0.05, Fig. 6 ), although at the highest concentration tested, the anti-c-fms antibody was consistently less effective: This phenomenon may reflect ligandindependent but antibody-mediated aggregation and activation of c-fms. These antibodies were also tested against purified recombinant SCF, GM-CSF, and M-CSF to confirm their specificity: Both antibodies inhibited monocyte cluster formation by M-CSF, but neither affected the ability of SCF or GM-CSF to generate granulocyte clusters (data not shown); thus, the antibodies were specific for the M-CSF ligand or receptor. Antibodies to another surface molecule (cytokeratin-19) or growth factor (anti-SCF antibody) had no effect on NPA production (Fig. 6) . The apparent inhibition of NPA production by the anticytokeratine antibody at the highest concentration tested was a result of cellular toxicity. Thus, specifically blocking M-CSF function during the production of the CM by G
cells reduces NPA production to the levels observed in
Differential expression of cytokines in media conditioned by M-CSF-deficient mice
We attempted to identify the cytokine(s) responsible for NPA by screening CM with or without NPA activity using commercial cytokine arrays (Fig. 7) . Membrane arrays were incubated with CM from G, GM Ϫ/Ϫ , M-CSF ϩ/Ϫ embryonic fibroblasts exposed to control medium or to medium containing LPS (Fig.  7, A and B) or with CM from G, GM Ϫ/Ϫ , M-CSF Ϫ/Ϫ embryonic fibroblasts exposed to LPS (Fig. 7C) . All CM were prepared at the same time and under identical conditions. It was clear that LPS strongly enhanced the secretion of some cytokines, which are already present in unstimulated CM Embryonic fibroblasts from mice homozygous null for G-CSF and GM-CSF and null (-/-) or heterozygous (ϩ/-) for M-CSF were established from Day 0, with or without added M-CSF (5 ng/ml) in the culture medium. Within each treatment group, MEFs at Passage 2 were reseeded and stimulated with LPS (0.05 g/ml), alone or in combination with M-CSF (5 ng/ml), for 48 hr. Data are expressed in NPA units/ml and are the average ϩ/-SD of three independent experiments. Two-tailed P values for each pairwise comparison were calculated using the paired t-test.
(KC and TIMP-1) and induces the secretion of cytokines absent in control media: eotaxin, IL-6, IL-12(p40), MIP-1␣, MIP-2, and (weakly) VEGF. However, only MIP-1␣, IL-12(p40), and VEGF were absent in the CM from triple (G, GM, M-CSF)-KO fibroblasts, and the amount of IL-6 was reduced significantly. Thus, the presence or amounts of MIP-1␣, IL-12(p40), VEGF, and IL-6 correlated with NPA activity. We assessed the contribution to NPA activity of these cytokines by testing purified or commercially available recombinant proteins in the standard bone marrow assay. VEGF, MIP-1␣, and IL-12 were completely negative in the NPA assay, and IL-6 was partially active but reached plateau at levels well below those of NPA ( Table 2) . Thus, the identity of NPA remains, for the moment, elusive.
Although the arrays used include only a subset of known cytokines, they do allow a partial view of the secreted/released proteins in the CM as well as providing a basis for excluding cytokines as having NPA activity. For example, IL-3 and SCF were, theoretically at least, candidates for NPA on the basis of their biological activity. IL-3 and SCF antibodies were present on the array (Fig. 7D ) but did not show reactivity with any of the CM, thus making it unlikely that these factors correspond to or contribute to NPA activity.
DISCUSSION
Growth factor-and cytokine-deficient mice have provided important insights into the functions of growth factors/cytokines. A number of studies have demonstrated that G-CSF/GM-CSF double-KO mice have chronic neutropenia, granulocyte and macrophage progenitor cell deficiency, impaired neutrophil mobilization [5] , impaired reproductive capacity, perturbed neonatal granulopoiesis, and amyloidosis [10] . Yet, these mice develop profound neutrophilia and have elevated numbers of GM and M progenitors in the bone marrow after acute infection with pathogenic organisms [12] . Thus, there exist G-CSF/GM-CSF-independent pathways for the generation of granulocytes in emergency states.
In this study, we have used an in vitro system to help define the factor(s) that promote granulocyte generation in G-CSF/ GM-CSF double-KO mice during infection. We have shown that embryonic fibroblasts from G-CSF/GM-CSF double-KO mice produce high levels of a NPA after stimulation with pathogens, such as HI C. albicans, or gram-negative bacterial components, such as LPS. The CM from these cells sustained a mixed population of early myeloid cells (as defined by Flt-3 positivity), which also expressed the myeloid markers Mac-1 and Gr-1. It is surprising that given the absence of G-CSF and GM-CSF, bone marrow progenitors exposed to NPA give rise to cells with the morphological, antigenic, and enzymatic characteristics of true granulocytes.
We have identified a crucial role for M-CSF in mediating LPS or C. albicans induction of NPA. Neither LPS nor C. albicans was able to elicit NPA production in cells derived from G Ϫ/Ϫ GM Ϫ/Ϫ /M Ϫ/Ϫ mice. Furthermore, neutralizing antibodies to M-CSF or the c-fms abolished NPA production from cells, expressing a functional M-CSF gene product; furthermore, addition of M-CSF to the MEF cultures partially restored NPA production. Our data therefore directly implicate M-CSF in NPA production by primary and immortalized MEFs and suggest that it plays an important regulatory role in granulocyte production in the G Ϫ/Ϫ GM Ϫ/Ϫ mice. It is well recognized that M-CSF influences the proliferation and differentiation of hematopoietic stem cells along the monocyte/macrophage lineage and that M-CSF plays a critical role in LPS-induced macrophage activation [30] . The macrophage lineage comprises a collection of cell types responsible for numerous metabolic, immunological, and inflammatory processes in physiological and pathological conditions [31] . op/op mice [32] are deficient in M-CSF and provide a unique model to understand the roles of M-CSF in development, physiology, and pathology. It has been shown that op/op mice lack a population of macrophages dependent on M-CSF, and the M-CSF-independent macrophage population, which resides in op/op mice, is primarily responsible for the classical macrophage functions in immunity, such as phagocytosis and antigen processing [15] . The M-CSF-dependent macrophage population (absent in op/op mice) is primarily responsible for the regulatory functions of these cells, mediated by monokines. Thus, op/op mice have profound secondary deficiencies in cytokines secreted by this macrophage population, such as TNF-␣, IL-1, and G-CSF [33, 34] . In this context, it is not surprising that NPA secretion was also defective in mice null for M-CSF.
Despite a clear role for M-CSF in the production of NPA, the addition of exogenous M-CSF to G Ϫ/Ϫ GM Ϫ/Ϫ M Ϫ/Ϫ embryonic fibroblasts could only partially rescue NPA production, even when added to the cultures from the moment of MEF isolation. Other groups have shown that the deficiency of some tissue macrophage population in op/op mice is at most only partially corrected by injection of M-CSF [35] . Thus, it is likely that NPA is secreted by a M-CSF-responsive cell population, which is absent or reduced in the G Ϫ/Ϫ GM Ϫ/Ϫ M Ϫ/Ϫ cultures. We have not attempted in this study to identify or specifically select the cell population responsible for NPA secretion; however, the availability of our immortalized and clonally selected cell lines renders this identification possible in the future.
The identity of the cytokine(s) responsible for NPA activity remains to be determined: We have ruled out two of the most Purified murine cytokines and ILs were tested in the standard bone marrow assay in the concentration range suggested by the manufacturers. Slides were stained with May-Grumwald Giemsa, and the number of granulocyte clusters per well was determined as described in Materials and Methods and in the legend to Figure  1 . Numbers are the mean and SD of duplicate determinations.
a NPA (CM from LPS-stimulated SV#23 cells) and VEGF (partially purified form CHO CM, bioactive) were tested at the optimal dilution for the respective bioassays.
likely candidates, IL-3 and SCF, as well as other chemokines and cytokines such as IL-8, RANTES, and VEGF (Fig. 7 and  data not shown) . IL-6 may contribute to NPA activity but cannot replace NPA for the generation of granulocytes from bone marrow cells in mice lacking G-CSF and GM-CSF. Thus, granulopoiesis, particularly during exposure to pathogens, can be mediated by a variety of growth factors and cytokines with apparently redundant functions.
We suggest that production of NPA may play a role in emergency granulopoiesis in vivo and that M-CSF is pivotal in mediating this response. Of the cell types capable of mediating an immunological response to pathogens, the monocyte/macrophage lineage and the dendritic cell lineage, which share a a common precursor [36] , are candidates for in vivo NPA-producing cells: Both secrete a plethora of cytokines and ILs [7, 27, 37, 38] , express c-fms [36, 39] , and are induced by M-CSF to differentiate and acquire functional capacity [40, 41] . The important question is, of course, why there should be many cytokines with overlapping or redundant roles and what the function of NPA may be in an organism expressing functional G-CSF and GM-CSF genes. It is tempting to speculate that "NPA" and the classical granulocyte growth and differentiation factors (G-CSF and GM-CSF) may have differential temporal induction following exposure to pathogens, thus ensuring continuing and sustained production of neutrophils during infection. Unfortunately, a direct test of this hypothesis will have to await the identification of the cytokine(s) responsible for NPA and the direct measurement of its presence, activity, and biological relevance in normal mice.
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